Truace
Subscribe

AI-assisted digital thyroid FNA cytology for Bethesda risk stratification

Source article: Artificial intelligence-assisted digital thyroid FNA cytology: Improved agreement and sensitivity for higher-risk Bethesda categories with enhanced screening efficiency

Background Accurate cytologic classification of thyroid nodules is essential for clinical management, but interobserver variability and indeterminate interpretations remain persistent challenges. The clinical feasibility of AIxTHY, a disease-specific deep-learning algorithm integrated into a digital cytology platform, was evaluated for assisting thyroid fine-needle aspiration (FNA) diagnosis using whole-slide imaging (WSI). Methods Two cytopathologists and one cytologist independently reviewed 100 archival ThinP…

By the Truvace desk2 min read1 sourcePeer-reviewedTRV-2026-1235· cite & verify
Artificial intelligence-assisted digital thyroid FNA cytology: Improved agreement and sensitivity for higher-risk Bethesda categories with enhanced screening efficiency
"Respiratory bronchiolitis" by Pulmonary Pathology is licensed under CC BY-SA 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-sa/2.0/.
Trace impact readingPositive state
P 71The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 76The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

In a 100-slide archival study, two cytopathologists and one cytologist reviewed thyroid fine-needle aspiration cases using microscopy and two AI-assisted whole-slide imaging modes powered by the AIxTHY algorithm. By the October 2026 publication date, the authors reported improved agreement with expert consensus for higher-risk Bethesda categories and a 40% to 65% reduction in review time.

The findings matter because thyroid nodule triage depends on accurate Bethesda classification, where interobserver variability and indeterminate results affect management. While sensitivity and workflow efficiency improved, specificity fell due to false positives in indeterminate lesions, leaving uncertainty about clinical impact, generalizability beyond the small reviewer group, and performance on prospective cases.

Main points

  1. Study evaluated AIxTHY, a disease-specific deep-learning algorithm integrated into a digital cytology platform using whole-slide imaging.
  2. Two cytopathologists and one cytologist independently reviewed 100 archival ThinPrep FNA slides across microscopy, AI-assisted single-layer WSI, and AI-assisted seven-layer Z-stack WSI with 2-week washout intervals.
  3. For binary risk stratification TBS III+ vs TBS II, sensitivity rose from 60% to 78% to 79% and accuracy from 61% to approximately 71% with AI assistance.
  4. Review time fell by 40% to 65% across diagnostic categories with AI-assisted modalities.

The gain

AIxTHY-assisted digital cytology increased sensitivity for higher-risk Bethesda categories and improved agreement with expert consensus while cutting slide review time.

The problem

AI assistance reduced specificity because of increased false-positive classifications, particularly among indeterminate thyroid cases.

The rundown

Researchers tested AIxTHY on 100 archival ThinPrep thyroid FNA slides, comparing microscopy to AI-assisted single-layer and seven-layer Z-stack whole-slide imaging. Three reviewers assigned Bethesda categories with washout intervals, using expert cytologic consensus as ground truth and recording review times.

AI-assisted modalities showed higher agreement for TBS III+ categories and less downgrading versus microscopy, with sensitivity gains from 60% to 78-79% for TBS III+ versus TBS II. The trade-off was lower specificity from false positives in indeterminate cases, and authors noted feasibility as an adjunct pending specificity improvements.

What this doesn’t fix

Specificity decreased with AI assistance due to false positives in indeterminate lesions, indicating need for further refinement before routine clinical use.

Sources

  1. Peer-reviewedCancer Cytopathology2026-10-01

The debate